| Aspen Psychotherapy Pllc | |
|
1011 W Maple St Ste 150 Kalamazoo MI 49008-5805 | |
| (269) 224-2559 | |
| Not Available |
| Full Name | Aspen Psychotherapy Pllc |
|---|---|
| Speciality | Psychologist |
| Location | 1011 W Maple St Ste 150, Kalamazoo, Michigan |
| Authorized Official Name and Position | Mary Beth Houpt (CREDENTIALING) |
| Authorized Official Contact | 5176769788 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Aspen Psychotherapy Pllc Po Box 10 Mason MI 48854-0010 Ph: () - | Aspen Psychotherapy Pllc 1011 W Maple St Ste 150 Kalamazoo MI 49008-5805 Ph: (269) 224-2559 |
| NPI Number | 1083238703 |
|---|---|
| Provider Enumeration Date | 05/29/2020 |
| Last Update Date | 05/29/2020 |
| Certification Date | 05/29/2020 |
| Medicare PECOS PAC ID | 9931522273 |
|---|---|
| Medicare Enrollment ID | O20200706001568 |
News Archive
The Food and Drug Administration (FDA) has given the Blanchette Rockefeller Neurosciences Institute (BRNI) the go-ahead to conduct Phase II clinical trials of Bryostatin for the treatment of Alzheimer's disease patients.
Researchers at Columbia University, in collaboration with biologists in Baylor College of Medicine, have made a significant step in understanding and imaging protein synthesis, pinpointing exactly where and when cells produce new proteins.
Medical College of Georgia researchers are conducting the first FDA-approved clinical trial to determine whether an infusion of stem cells from umbilical cord blood can improve the quality of life for children with cerebral palsy.
Life-extending drugs debut frequently, and they usually seem exorbitantly expensive when weighed against their promise of adding a few weeks or months of life to someone with a terminal illness. In these prostate-cancer cases, one new drug costs $5,000 a month, another $8,000 every three weeks and a third $93,000 for a full course of treatment.
Full risk or preferably the safe option? Based on the neuronal activity in the prefrontal cortex of the brain, it is possible to predict what action will be chosen next: If the activity of specific neurons remains low, a risk will be taken again at the next opportunity.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083238703 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | (* (Not Available)) | Primary |
| Provider Name | Melissa Therese Heinrich |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1841763166 PECOS PAC ID: 1759704091 Enrollment ID: I20200706001651 |
News Archive
The Food and Drug Administration (FDA) has given the Blanchette Rockefeller Neurosciences Institute (BRNI) the go-ahead to conduct Phase II clinical trials of Bryostatin for the treatment of Alzheimer's disease patients.
Researchers at Columbia University, in collaboration with biologists in Baylor College of Medicine, have made a significant step in understanding and imaging protein synthesis, pinpointing exactly where and when cells produce new proteins.
Medical College of Georgia researchers are conducting the first FDA-approved clinical trial to determine whether an infusion of stem cells from umbilical cord blood can improve the quality of life for children with cerebral palsy.
Life-extending drugs debut frequently, and they usually seem exorbitantly expensive when weighed against their promise of adding a few weeks or months of life to someone with a terminal illness. In these prostate-cancer cases, one new drug costs $5,000 a month, another $8,000 every three weeks and a third $93,000 for a full course of treatment.
Full risk or preferably the safe option? Based on the neuronal activity in the prefrontal cortex of the brain, it is possible to predict what action will be chosen next: If the activity of specific neurons remains low, a risk will be taken again at the next opportunity.
› Verified 6 days ago
News Archive
The Food and Drug Administration (FDA) has given the Blanchette Rockefeller Neurosciences Institute (BRNI) the go-ahead to conduct Phase II clinical trials of Bryostatin for the treatment of Alzheimer's disease patients.
Researchers at Columbia University, in collaboration with biologists in Baylor College of Medicine, have made a significant step in understanding and imaging protein synthesis, pinpointing exactly where and when cells produce new proteins.
Medical College of Georgia researchers are conducting the first FDA-approved clinical trial to determine whether an infusion of stem cells from umbilical cord blood can improve the quality of life for children with cerebral palsy.
Life-extending drugs debut frequently, and they usually seem exorbitantly expensive when weighed against their promise of adding a few weeks or months of life to someone with a terminal illness. In these prostate-cancer cases, one new drug costs $5,000 a month, another $8,000 every three weeks and a third $93,000 for a full course of treatment.
Full risk or preferably the safe option? Based on the neuronal activity in the prefrontal cortex of the brain, it is possible to predict what action will be chosen next: If the activity of specific neurons remains low, a risk will be taken again at the next opportunity.
› Verified 6 days ago
True2u Counseling Llp Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4000 Portage St Ste 111, Kalamazoo, MI 49001 Phone: 269-365-0128 | |
Dawn Wood Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3503 Greenleaf Blvd Ste 202, Kalamazoo, MI 49008 Phone: 269-808-0160 | |
David L. Thayer, Psy.d.,p.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 821 W South St, Suite D, Kalamazoo, MI 49007 Phone: 269-501-3493 Fax: 269-344-5973 | |
Barbara W. Gustin, Lmsw, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2001 Hudson Ave, Kalamazoo, MI 49008 Phone: 269-352-6644 | |
Jennifer Langeland Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 S Rose St Apt 401, Kalamazoo, MI 49007 Phone: 269-330-4695 | |
Rootead Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1501 Fulford St, Kalamazoo, MI 49001 Phone: 269-358-8670 | |
Restorative Solutions Counseling And Consulting Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2031 Rambling Rd Ste 1, Kalamazoo, MI 49008 Phone: 269-224-2791 |